All Stories

  1. Ensuring access to ‘access’ antibiotics: an imminent consideration for sustainable antimicrobial stewardship in the developing world
  2. Reporting of adverse drug reactions in India: A review of the current scenario, obstacles and possible solutions
  3. The Promise of Dolutegravir: A Novel Second Generation Integrase Strand Transfer Inhibitor
  4. Vedolizumab: A novel anti-integrin drug for treatment of inflammatory bowel disease
  5. Obinutuzumab for chronic lymphocytic leukemia: promise of the first treatment approved with breakthrough therapy designation
  6. Patent cliff mitigation strategies: giving new life to blockbusters
  7. Management of Parkinson׳s disease: Current and future pharmacotherapy
  8. Drug treatment of obesity: Current status and future prospects
  9. Bedaquiline for the treatment of resistant tuberculosis: Promises and pitfalls
  10. GLP-1 receptor agonists and the risk of colorectal cancer
  11. The Evolving Drug Development Landscape: From Blockbusters to Niche Busters in the Orphan Drug Space
  12. Current Issues With the Use of Bedaquiline
  13. Pattern of surgical antibiotic prophylaxis in a tertiary care teaching hospital in India
  14. Pattern of surgical antibiotic prophylaxis in a tertiary care teaching hospital in India